The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...

Weekly insulin injections can control type 1 and type 2 diabetes just as well as daily shots, according to two new studies.

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators ... forced ...

A specific type of diabetes medication has been associated with ... The scientists also didn't differentiate between participants taking insulin to control their blood sugars and those not doing ...

Diabetes home tests can help you track blood sugar levels throughout the month and complement tests done at the doctor’s office. Knowing when and how to use them can help you manage diabetes and ...

Embecta Corp. focuses on diabetes products and recently received FDA approval for a new patch pump. Read why I'm neutral on ...

SGLT2 inhibitors had been introduced as a new treatment for diabetes. These drugs not only lower blood sugar but also increase urinary glucose excretion, which leads to reduced insulin levels and ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

The retrospective study involved reviewing the medical charts of 100 adults with T1D ... All of the participants were taking insulin for their diabetes. Insulin pumps were used by 75% of those ...